Exhibit 99.3
Consent to be Named as a Director Nominee
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Louis G. Lange | ||||||
| Date: July 15, 2021 | Name: Louis G. Lange, M.D., Ph.D. |
Consent to be Named as a Director Nominee
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Stephen Sherwin | ||||||
| Date: July 15, 2021 | Name: Stephen Sherwin, M.D. |
Consent to be Named as a Director Nominee
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Jonathan Rigby | ||||||
| Date: July 15, 2021 | Name: Jonathan Rigby |
Consent to be Named as a Director Nominee
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Glen Giovanetti | ||||||
| Date: July 15, 2021 | Name: Glen Giovanetti |
Consent to be Named as a Director Nominee
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Ronald Eastman | ||||||
| Date: October 31, 2021 | Name: Ronald Eastman |
Consent to be Named as a Director Nominee
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Shawn Cross | ||||||
| Date: November 10, 2021 | Shawn Cross |
Consent to be Named as a Director Nominee
In connection with the filing by BioPlus Acquisition Corp. of the Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of BioPlus Acquisition Corp. in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ Ross Haghighat | ||||||
| Date: November 10, 2021 | Ross Haghighat |
